The individual risk is influenced by the primary disease and its treatment, such as the antiresorptive medication (substance, duration of application, frequency of application), concomitant therapy, further diseases (e.g. diabetes), further treatments (e.g. head and neck radiation), further factors (e.g. smoking) and existence of former osteonecrosis/present osteonecrosis.
This impairment was significantly related to type of substance, duration of use and number of hospitalization and may contribute to most of behavioral disturbances found in addicts and need much attention during tailoring of treatment programs.
In a number of patients (around 50%), GC therapy causes adrenal suppression, probably mainly due to as yet undefined individual factors (apart from dose, substance and duration of therapy).
They did not differ in number or type of intake, number of substances used, type of substances used, months of abstinence, number of relapses, age of onset of substance use or duration of SUD disorder.
Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa.
Of relevance to this analysis, questionnaire data were collected surrounding sociodemographic characteristics, symptoms of mental illness, patterns of substance use and duration of homelessness.
Consequently, analyses were adjusted by propensity score stratification [ 16, 17] based on study site, age, gender, race, baseline BPRS total score, initial therapy, health insurance status, substance abuse diagnosis, duration of any past hospitalizations, and illness duration.
The average duration of substance misuse was five years.
Duration of substance abuse may have impact on quality of sleep.
Thus, we also hypothesized that self-reported poor sleep quality would be associated with the longer duration of substance use.
Also, no data about duration of substance abuse (previous or after the beginning the dialysis) were collected.
